SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (7)9/25/1996 2:22:00 AM
From: PAUL ROBERT ST. ONGE   of 127
 
Andrx marketing of itself could be better, read the facts! Even if you can not bet the house, buy some shares now. Look beyond the ANDA's and you may get a feel for what is exciting all those investors. Rumor is that someone has been buying Watson shares, possible buy-out down the line. The Circa story may have some teeth, Watson realized the overall market potential verses Andrx and realized they may be the little company. Andrx drug delivery technolgy can easily surpass a company that is pretty much limited to the generic market. Were not talking just generics were also talking branded as well. You know the big guys implemting a technolgy that can be applied to almost any drug. Last, your relying on whats on the table now. Wise to do so, but again review their current deals, review the package, think of the usefullness of this technolgy and its benefits to almost all drug producers. You have a very exciting company!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News